Michael Wiederhorn
Stock Analyst at Oppenheimer
(3.63)
# 701
Out of 4,792 analysts
137
Total ratings
51.88%
Success rate
3.59%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CI The Cigna Group | Maintains: Outperform | $400 → $375 | $338.45 | +10.80% | 11 | Jan 31, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $14 → $12 | $7.53 | +59.36% | 11 | Jan 24, 2025 | |
| CNC Centene | Maintains: Outperform | $95 → $85 | $64.29 | +32.21% | 17 | Dec 13, 2024 | |
| UNH UnitedHealth Group | Maintains: Outperform | $610 → $640 | $540.44 | +18.42% | 14 | Dec 6, 2024 | |
| PNTG The Pennant Group | Maintains: Outperform | $34 → $37 | $25.57 | +44.70% | 6 | Nov 8, 2024 | |
| HCA HCA Healthcare | Maintains: Outperform | $390 → $400 | $349.14 | +14.57% | 11 | Oct 28, 2024 | |
| ENSG The Ensign Group | Maintains: Outperform | $165 → $168 | $133.90 | +25.47% | 8 | Oct 25, 2024 | |
| HUM Humana | Maintains: Outperform | $400 → $280 | $265.48 | +5.47% | 12 | Oct 3, 2024 | |
| ADUS Addus HomeCare | Maintains: Outperform | $140 → $145 | $101.33 | +43.10% | 10 | Sep 23, 2024 | |
| PACS PACS Group | Maintains: Outperform | $32 → $40 | $9.70 | +312.37% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4.5 → $5 | $2.53 | +97.63% | 10 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | n/a | $8.51 | - | 2 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $650 | $619.21 | +4.97% | 12 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $145 | $92.99 | +55.93% | 10 | Oct 28, 2022 |
The Cigna Group
Jan 31, 2025
Maintains: Outperform
Price Target: $400 → $375
Current: $338.45
Upside: +10.80%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $14 → $12
Current: $7.53
Upside: +59.36%
Centene
Dec 13, 2024
Maintains: Outperform
Price Target: $95 → $85
Current: $64.29
Upside: +32.21%
UnitedHealth Group
Dec 6, 2024
Maintains: Outperform
Price Target: $610 → $640
Current: $540.44
Upside: +18.42%
The Pennant Group
Nov 8, 2024
Maintains: Outperform
Price Target: $34 → $37
Current: $25.57
Upside: +44.70%
HCA Healthcare
Oct 28, 2024
Maintains: Outperform
Price Target: $390 → $400
Current: $349.14
Upside: +14.57%
The Ensign Group
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $133.90
Upside: +25.47%
Humana
Oct 3, 2024
Maintains: Outperform
Price Target: $400 → $280
Current: $265.48
Upside: +5.47%
Addus HomeCare
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $101.33
Upside: +43.10%
PACS Group
Aug 13, 2024
Maintains: Outperform
Price Target: $32 → $40
Current: $9.70
Upside: +312.37%
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $2.53
Upside: +97.63%
Mar 7, 2024
Maintains: Perform
Price Target: n/a
Current: $8.51
Upside: -
Feb 29, 2024
Maintains: Outperform
Price Target: $625 → $650
Current: $619.21
Upside: +4.97%
Oct 28, 2022
Maintains: Outperform
Price Target: $175 → $145
Current: $92.99
Upside: +55.93%